Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche presents interim results from part 1 of FIREFISH study of risdiplam

July 15, 2019

Results presented from phase III EAT2TREAT study of fampridine and acetazolamide

July 15, 2019

Recruitment ongoing in phase I study of BI-836880 for the treatment of wAMD

July 15, 2019

EIP Pharma initiates phase II study of neflamapimod in cognitive dysfunction associated with DLB

July 15, 2019

Allist Pharmaceuticals initiates phase III FLAG study of alflutinib mesylate in NSCLC

July 15, 2019

Slt-deficient F. novicida mutant shows attenuation and protects against pneumonic challenge in mice

July 15, 2019

Human biodistribution and dosimetry of the PET imaging agent [11C]trimethoprim

July 12, 2019

Beta Pharma enrolling patients with NSCLC for phase III trial of BPI-7711

July 12, 2019

Study in humans determines biodistribution of COX-1 PET radioligand [11C]PS-13

July 12, 2019

First patient enrolled in phase I study of GST-HG-161

July 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.